IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment

Table 7

Correlation between the AG Ab level and clinical parameters of patients.

Abs	Parameter
Adi in F0	Viral load	25	0.47	0.017
Adi in F0–1	Viral load	35	0.44	0.008
Adi in F0–4	Viral load	62	0.37	0.012
Adi in F0–4	Anti-HCV Abs	35	−0.61	0.001
Adi	Monocytes (count/mL)	54	−0.32	0.017
GA2 in F0–4	Anti-HCV Abs	38	0.39	0.017
GA2 in F0–4	AFP	29	0.63	<0.001
Gb5tri in F0–4	ALP	67	0.37	0.002
Gb5tri in F1–4	ALP	43	0.46	0.002
TFβ in F1–4	ALP	43	0.38	0.025
Viral load	Anti-HCV Abs	38	−0.40	0.042
Tn	Lymphocytes (count/mL)	35	−0.52	0.002
GalNAcβ	Bilirubin	53	0.31	0.024

denotes Spearman’s correlation coefficient.